FDA Approves Rayaldee for Chronic Kidney Disease with Secondary Hyperparathyroidism
News
The U.S. Food and Drug Administration (FDA) has recently approved OPKO Health’s Rayaldee (calcifediol) capsules for the treatment of secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) ... Read more